RETRACTED: Treatment trajectories among children and adolescents referred to the Norwegian National Center for Gender Incongruence
Acta Paediatrica · 2025
DOI: 10.1111/apa.17530 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Cecilie Bjertness Nyquist und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Paediatric and Adolescent Medicine, Department of Child and Adolescent Mental Health in Hospitals, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Gender Dysphoria, Gender-Affirming Procedures. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Helse Sør-Øst RHF.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
We aimed to describe treatment trajectories, detransition and mortality rate among children and adolescents referred to the Norwegian National Center for Gender Incongruence (NCGI).
Methods
The cohort included all 1258 persons under 18 years at referral to the NCGI from 2000 to 2020. Trajectories were registered until end of 2023.
Results
In total, 861/1258 (68.4%) were assigned female gender at birth (AFAB). Mean age at referral was 14.4 years. Puberty suppression with gonadotropin‐releasing hormone agonists (GnRHa) was initiated among 135/1258 (10.7%), significantly more persons assigned male gender at birth (AMAB) than AFAB ( p < 0.001). Gender‐affirming hormonal treatment (GAHT) was initiated in 783/1258 (62.2%). The continuation rate from GnRHa to GAHT was 97%. Discharge rate from NCGI without gender‐affirming medical treatment among those who attended at least one appointment, was 264/1198 (22.0%). Eighteen AFAB detransitioned after initiated GAHT, eleven due to a cessation of transgender identity. Mortality rate in the cohort until end of 2023 was 11/1258 (0.9%).
Conclusion
Different trajectories including medical pathways and assessments without gender‐affirming treatment were observed. GAHT was initiated in 783/1258 (62.2%), including eighteen AFAB detransitioning after testosterone treatment. There was a high continuation rate from GnRHa to GAHT. Various trajectories highlights the need for long‐term follow‐up in care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Paediatric and Adolescent Medicine, Department of Child and Adolescent Mental Health in Hospitals, Oslo University Hospital, Oslo, Norway.
- Division of Paediatric and Adolescent Medicine, Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.
- Department of Gender Identity Assessment, Norwegian National Center for Gender Incongruence, Oslo University Hospital, Oslo, Norway.
ORCID-Profile: Cecilie Bjertness Nyquist, Leila Torgersen, Linda W David, Trond Haaken Diseth, Kjersti Gulbrandsen, Anne Waehre
Förderung
- Helse Sør-Øst RHF
Zitieren
APA
Nyquist, C. B., Torgersen, L., David, L. W., Diseth, T. H., Gulbrandsen, K., & Waehre, A. (2025). RETRACTED: Treatment trajectories among children and adolescents referred to the Norwegian National Center for Gender Incongruence. Acta Paediatrica. https://doi.org/10.1111/apa.17530
Vancouver
Nyquist CB, Torgersen L, David LW, Diseth TH, Gulbrandsen K, Waehre A. RETRACTED: Treatment trajectories among children and adolescents referred to the Norwegian National Center for Gender Incongruence. Acta Paediatrica. 2025. doi:10.1111/apa.17530
BibTeX
@article{Nyquist2025,
author = {Nyquist, Cecilie Bjertness and Torgersen, Leila and David, Linda W and Diseth, Trond Haaken and Gulbrandsen, Kjersti and Waehre, Anne},
title = {RETRACTED: Treatment trajectories among children and adolescents referred to the Norwegian National Center for Gender Incongruence},
journal = {Acta Paediatrica},
year = {2025},
doi = {10.1111/apa.17530}
}
EUVIMED